[February 21, 2013] |
|
CDRD Ventures Inc., and Pfizer Announcement Showcases Today's Investment for Health Innovation
VANCOUVER, British Columbia --(Business Wire)--
BIOTECanada, the national industry association representing 250
biotechnology companies today congratulates CDRD Ventures Inc., (CVI),
the commercialization vehicle of The Centre for Drug Research and
Development (CDRD) and Pfizer on their announcement of a new strategic
collaboration aimed at advancing Canada's most promising health
technologies towards commercialization.
"Canada is home to hundreds of research enterprises in almost every
region across the country developing truly game-changing therapies and
treatments to significantly improve health care for thousands of
Canadians, and thousands more globally, who suffer from debilitating or
life threatening illnesses," commented Andrew Casey, President and CEO
BIOTECanada. "The success of these udertakings is highly dependent on
capital and partnerships with larger biotechnology companies. The
CVI-Pfizer partnership announced today serves as an excellent example of
the new biotech-health business model where commercialized companies
interconnect with smaller companies and research enterprises fostering
an eco-system to move research from an idea in the lab to a bona fide
treatment in the health care system."
Biotechnology plays an important role as a preventative tool and modern
treatments for cancer, blood disorders and respiratory illness in the
health care system. Screening patients for susceptibility to disease and
providing vaccinations has impacted millions of Canadians. With
biotechnology, we can glean understanding of our genetic code, improving
our collective health. These advances offer doctors the tools to prevent
and cure diseases with a personalized approach.
The Canadian life sciences sector continues to show determination and
resiliency. The industry is seeking in excess of $1 billion of capital
to help Canadian companies grow and develop. Through diverse products
and process developments, Canadian biotechnology companies are boosting
commercial productivity in agriculture, healthcare, energy, and advanced
manufacturing.
BIOTECanada is the national industry association with nearly 250 members
located nation wide, reflecting the diverse nature of Canada's health,
industrial and agricultural biotechnology sectors.
[ Back To TMCnet.com's Homepage ]
|